Neuromuscular HOMEepAGE
neuromuscular.wustl.edu
/
A–Z

Granulomatous & Inflammatory Myopathies with Anti-mitochondrial antibodies

VariableMitochondrialImmune/AntibodyOMIM 608770
W
View full entry on WUSTL Neuromuscular
antibody/infmyop.htm#Granulomatous & Inflammatory Myopathies with Anti-mitochondr

Overview

From WUSTL Neuromuscular

Epidemiology Geography Tokyo: 11% of inflammatory myopathies France: 8% of IIM Female:Male = 15:9 Clinical Onset age: 33 to 72 years; Mean 49 years Systemic Primary biliary cirrhosis: 30%; Often asymptomatic Cardiac: 33% to 71% Arrhythmias: Atrial tachycardia Cardiomyopathy: Reduced ejection fraction Myocarditis 20% Associated with Biliary cirrhosis Muscle Weakness Proximal > Distal Arms & Legs Moderate degree: 3/5 to 4/5 Scapular winging Paraspinal (11%) Atrophy: 55% Respiratory: Reduced vital capacity 33% Course: Chronic 55% Skin rash: Uncommon Associated disorders Malignancy: 13%; Colon Oth

OMIM Entries

OMIM #608770

Related Conditions

Shared genes
IMPP (Myofasciitis; EVIM) + Deafness: Enterovirus & Hypogammaglobulinemia-Related
D68D71CLINICAL
Phosphoglycerate Kinase Deficiency
DPGPGACLINICAL
Vici syndrome
IICLINICAL

External Resources

WUSTL Neuromuscular
Washington University Disease Center
OMIM
Online Mendelian Inheritance in Man
PubMed
Biomedical Literature
GeneReviews
NCBI Expert-Authored Reviews
Orphanet
Portal for Rare Diseases
NORD
National Organization for Rare Disorders

Data sourced from the Washington University Neuromuscular Disease Center. For clinical use, always refer to primary sources.